Buchzusammenfassung
Scott Gottlieb is the former commissioner of the Food and Drug Administration in the US. He is also a contributor to CNBC and sits on the board of directors at the pharmaceutical company Pfizer. He is a member of the National Academy of Medicine and is considered one of the “50 People Transforming Healthcare” by Time magazine.
The US government initially treated the COVID-19 pandemic as a flu outbreak, a strategy rooted in preparations from 2005 under President George W. Bush. While the US had plans for flu pandemics and bioterrorism, it was unprepared for a coronavirus like SARS-CoV-2. Early efforts focused on surface disinfection and handwashing, failing to address the virus's respiratory transmission. Testing infrastructure was inadequate, with the CDC controlling virus samples and delaying widespread testing. Meanwhile, China's lack of transparency and the WHO's delayed pandemic declaration compounded the crisis. In contrast, South Korea, shaped by its 2015 MERS outbreak, had robust testing, stockpiles, and surveillance systems, enabling rapid containment. The US's fragmented response, marked by mismanagement, testing delays, and inconsistent messaging, highlighted the need for a coordinated federal approach to public health as a national security priority.
Um den Rest des Buches zu lesen, können Sie
Bitely herunterladen